Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness).

Eric Pearlman(University of California, San Francisco), J W Kazura(Case Western Reserve University), Eugenia Diaconu(University Hospitals of Cleveland), F E Hazlett(University Hospitals of Cleveland), Jonathan H. Lass(University Hospitals of Cleveland), Manfred Köpf(École Polytechnique Fédérale de Lausanne), David S. Bardenstein(Case Western Reserve University)
The Journal of Experimental Medicine
October 1, 1995
Cited by 85


Related Papers